Susquehanna International Group’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Hold |
0
| – | – | – | 6768 |
|
2024
Q2 | – | Sell |
-950,839
| Closed | -$4.11M | – | 6787 |
|
2024
Q1 | $4.11M | Sell |
950,839
-627,762
| -40% | -$2.71M | ﹤0.01% | 1165 |
|
2023
Q4 | $4.81M | Buy |
+1,578,601
| New | +$4.81M | ﹤0.01% | 1174 |
|
2023
Q3 | – | Sell |
-12,471
| Closed | -$31.1K | – | 6565 |
|
2023
Q2 | $31.1K | Sell |
12,471
-308,802
| -96% | -$769K | ﹤0.01% | 5294 |
|
2023
Q1 | $861K | Sell |
321,273
-56,519
| -15% | -$151K | ﹤0.01% | 3107 |
|
2022
Q4 | $2.05M | Buy |
377,792
+203,830
| +117% | +$1.11M | ﹤0.01% | 1573 |
|
2022
Q3 | $2.17M | Buy |
173,962
+109,034
| +168% | +$1.36M | ﹤0.01% | 1585 |
|
2022
Q2 | $321K | Sell |
64,928
-34,467
| -35% | -$170K | ﹤0.01% | 3919 |
|
2022
Q1 | $755K | Sell |
99,395
-99,341
| -50% | -$755K | ﹤0.01% | 3166 |
|
2021
Q4 | $2.03M | Buy |
198,736
+34,290
| +21% | +$350K | ﹤0.01% | 1960 |
|
2021
Q3 | $2.21M | Buy |
164,446
+83,653
| +104% | +$1.12M | ﹤0.01% | 1860 |
|
2021
Q2 | $1.77M | Sell |
80,793
-52,651
| -39% | -$1.16M | ﹤0.01% | 2203 |
|
2021
Q1 | $3.21M | Sell |
133,444
-79,470
| -37% | -$1.91M | ﹤0.01% | 1615 |
|
2020
Q4 | $3.83M | Buy |
212,914
+157,546
| +285% | +$2.83M | ﹤0.01% | 1204 |
|
2020
Q3 | $640K | Buy |
55,368
+38,358
| +226% | +$443K | ﹤0.01% | 2758 |
|
2020
Q2 | $413K | Sell |
17,010
-9,110
| -35% | -$221K | ﹤0.01% | 3131 |
|
2020
Q1 | $288K | Buy |
26,120
+16,583
| +174% | +$183K | ﹤0.01% | 3468 |
|
2019
Q4 | $252K | Sell |
9,537
-14,561
| -60% | -$385K | ﹤0.01% | 3299 |
|
2019
Q3 | $549K | Sell |
24,098
-10,939
| -31% | -$249K | ﹤0.01% | 2792 |
|
2019
Q2 | $1.07M | Buy |
+35,037
| New | +$1.07M | ﹤0.01% | 1956 |
|
2019
Q1 | – | Hold |
0
| – | – | – | 4771 |
|
2018
Q4 | – | Hold |
0
| – | – | – | 5079 |
|
2018
Q3 | – | Hold |
0
| – | – | – | 4915 |
|